Revealing the role of regulatory b cells in cancer: development, function and treatment significance
- PMID: 39998678
- PMCID: PMC11861783
- DOI: 10.1007/s00262-025-03973-w
Revealing the role of regulatory b cells in cancer: development, function and treatment significance
Abstract
B cells are essential components of the immune response, primarily recognized for their ability to produce antibodies. However, emerging research reveals their important roles in regulating immune responses and influencing tumor development, independent of antibodies. The connection between tumor progression and alterations in the tumor microenvironment is well-established, as immune infiltrating cells can enhance the survival of tumor cells by modifying their surroundings. Despite this, the majority of studies have focused on T cells and macrophages, creating a gap in our understanding of B cells. Regulatory B cells (Bregs) represent a crucial subpopulation that plays a significant role in maintaining immune balance. They may have a substantial impact on tumor immunity by negatively regulating tumor-infiltrating immune cells. This paper reviews the existing literature on Bregs, examining their development, phenotypes, functions, and the mechanisms through which they exert their regulatory effects. Furthermore, we highlight their potential interventional roles and prognostic significance in cancer therapy. By addressing the current gaps in knowledge regarding Bregs within tumors, we hope to inspire further research that could lead to innovative cancer treatments and improved outcomes for patients.
Keywords: Breg cells; Breg development; Breg function; Breg subtypes; Cancer prognosis.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Conflict of interest: The authors declare no competing interests.
Figures


References
-
- Katz SI, Parker D, Turk JL (1974) B-cell suppression of delayed hypersensitivity reactions. Nature 251(5475):550–551 - PubMed
-
- Cencioni MT et al (2021) Defective CD19+CD24(hi)CD38(hi) transitional B-cell function in patients with relapsing-remitting MS. Mult Scler 27(8):1187–1197 - PubMed
-
- Gu Y et al (2020) Characterization of CD19(+) CD24(hi) CD38(hi) B cells in Chinese adult patients with atopic dermatitis. J Eur Acad Dermatol Venereol 34(12):2863–2870 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous